From evidence to action
At ICARS, our mission is to partner with Low- and Middle-income countries (LMICs) in their efforts to reduce drug-resistant infections. We do this by co-developing tailored solutions with LMIC governments and researchers, who then implement them on the ground using ICARS funding and expertise, building on AMR National Action Plans.
Follow us and view our latest news
ICARS – A Year in Review
In 2024, ICARS’ project portfolio expanded to 55 projects across 25 countries and territories, with seven new projects approved in Cambodia, Cameroon, Chile, Colombia, Kenya, and Tunisia. The year also saw the launch of four Requests for Proposals exploring AMR’s links to the environment, climate change, vaccines, and sustainability. As some projects near completion, promising early results—highlighted in this report from Colombia, Georgia, Kyrgyzstan, and Zambia—reflect ICARS’ growing role in bridging policy and research. ICARS intensified its advocacy efforts ahead of the UN General Assembly High-Level Meeting on AMR, co-hosting side events and receiving recognition in G7 and G20 health declarations. New capacity-strengthening initiatives were also launched, including antimicrobial stewardship training, a Community of Practice, and a gender and equity workshop in Bangkok. The ICARS partner network expanded significantly, with six new Mission Partners, a five-year collaboration with C-CAMP, support from the UK Department of Health and Social Care, and an expanded partnership with Canada’s IDRC. As ICARS continues to grow, it remains committed to delivering context-specific, country-owned solutions in partnership with low- and middle-income countries.
ICARS Strategy 2022 – 2026
Guided by our vision of a world without drug-resistant infections, we have developed a new strategy with a revised outcome framework and refined the scope and goals of each of our interconnected pillars.
We are pleased to present a succinct overview of ICARS unique value proposition, followed by our overarching strategy that will run until 2026, as well as a roadmap that details our planned activities per pillar.
Our projects inform policy and practice around the world
ICARS works with Low- and Middle-Income Countries around the world to tackle antimicrobial resistance and support the implementation of their AMR National Action Plans.
Join our mission
To achieve sustainable change in LMICs, we invite countries and foundations to join us as Strategic Funding Partners, Funding Partners or Mission Partners, in a truly international effort to mitigate antimicrobial resistance.
Please do not hesitate to contact our team for further information.
